← 483 OBSERVATION EXPLORER

FDA 483 OBSERVATION · #973 OF 1,000 MOST-CITED

Raw Material Control - Cleaning - Water Quality

FDA cited this observation 14 times across 13 firms in recent inspections. Below: how it breaks down by program area and fiscal year, and real examples of how FDA worded it on Form FDA 483.

BY PROGRAM AREA
Foods14
BY FISCAL YEAR
FY20221
FY20212
FY20202
FY20192
FY20187

How FDA worded it — real examples

You did not inspect, segregate or otherwise handle raw materials and other ingredients to ensure they were clean and suitable for processing.

Prico Produce, LLC · Caguas, Puerto Rico · Foods · 2022-01-31

You did not inspect, segregate or otherwise handle raw materials and other ingredients to ensure they were clean and suitable for processing.

Bake Fresh Colorado, LLC · Commerce City, Colorado · Foods · 2021-06-23

You did not inspect, segregate or otherwise handle raw materials and other ingredients to ensure they were clean and suitable for processing.

Bay Cities Italian Bakery, Inc. · Compton, California · Foods · 2021-03-19

You did not inspect, segregate or otherwise handle raw materials and other ingredients to ensure they were clean and suitable for processing.

Rubicon Bakers, LLC · Richmond, California · Foods · 2020-03-12

You did not inspect, segregate or otherwise handle raw materials and other ingredients to ensure they were clean and suitable for processing.

I Food Food Company · El Monte, California · Foods · 2019-11-15

You did not inspect, segregate or otherwise handle raw materials and other ingredients to ensure they were clean and suitable for processing.

Bake Fresh Colorado, LLC · Commerce City, Colorado · Foods · 2019-09-03

Related SPEQ references

Where to read the requirements behind this observation area on SPEQ. These are SPEQ's topic and audience pages — not an FDA classification of the citation.

Cleaning validationFood industry

Examples are a representative sample of FDA's published inspection observations. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →